Srivichaivejvivat PCLBKK:VIH-R 81 EV-to-EBIT is 6.89 as of Jul. 04, 2026, which is 46% below its 10-year median of 12.86. GuruFocus rates BKK:VIH-R with a GF Score™ of 81/100 and a GF Value™ of ฿8.96. The stock has 4 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Srivichaivejvivat PCL ranks better than 84.93% on this metric.
The historical rank and industry rank for Srivichaivejvivat PCL's EV-to-EBIT or its related term are showing as below:
BKK:VIH-R'
s EV-to-EBIT Range Over the Past 10 Years
Min: 2.13 Med: 12.86 Max: 37.67
Current: 6.9
During the past 13 years, the highest EV-to-EBIT of Srivichaivejvivat PCL was 37.67. The lowest was 2.13. And the median was 12.86.
BKK:VIH-R's EV-to-EBIT is ranked better than 84.93% of 471
companies
in the Healthcare Providers & Services industry
Industry Median: 15.78
vs BKK:VIH-R: 6.90
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Srivichaivejvivat PCL's Enterprise Value for the quarter that ended in Mar. 2026 was ฿4,107 Mil.
Srivichaivejvivat PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿551 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Srivichaivejvivat PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Srivichaivejvivat PCL EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Srivichaivejvivat PCL's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Srivichaivejvivat PCL's EV-to-EBIT falls into.
Srivichaivejvivat PCL's current Enterprise Value is ฿3,798 Mil.
Srivichaivejvivat PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿551 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Srivichaivejvivat PCL (BKK:VIH-R) has a EV-to-EBIT of 6.89 as of Jul. 04, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Srivichaivejvivat PCL and its competitors. This is 46% below median its historical median of 12.86. Over the past decade, Srivichaivejvivat PCL's EV-to-EBIT has ranged from 2.13 to 37.67. According to the industry distribution chart, Srivichaivejvivat PCL ranks #71 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 15.1%.
Is Srivichaivejvivat PCL's EV-to-EBIT too high?
Srivichaivejvivat PCL's current EV-to-EBIT of 6.89 is 46% below median its 10-year median of 12.86. Over the past 10 years, this metric has ranged from a low of 2.13 to a high of 37.67. The Healthcare Providers & Services industry median EV-to-EBIT is 15.78. Srivichaivejvivat PCL's value of 6.89 is 56.3% below this industry median. Based on the distribution chart, Srivichaivejvivat PCL ranks #71 out of 471 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Srivichaivejvivat PCL has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Srivichaivejvivat PCL's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Srivichaivejvivat PCL ranks #71 out of 471 companies for EV-to-EBIT. This places Srivichaivejvivat PCL in the top 15% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 15.78. Srivichaivejvivat PCL's value of 6.89 is 56.3% below this benchmark. Historically, Srivichaivejvivat PCL's own EV-to-EBIT has ranged from 2.13 to 37.67 over the past decade. While the company's 10-year median is 12.86 vs. the industry median of 15.78, Srivichaivejvivat PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.78, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Srivichaivejvivat PCL's current EV-to-EBIT of 6.89 is 56.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Srivichaivejvivat PCL and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Srivichaivejvivat PCL's current EV-to-EBIT is 6.89, which is 46% below median its own 10-year median of 12.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Srivichaivejvivat PCL stock overvalued right now?
Srivichaivejvivat PCL (BKK:VIH-R) has a current EV-to-EBIT of 6.89. The stock's GF Value™ is ฿8.96, compared to a current price of ฿8.95 — trading 0.1% below its estimated fair value. The current EV-to-EBIT is 6.89, which is 46% below median its 10-year median of 12.86 and 56.3% below the Healthcare Providers & Services industry median of 15.78. Srivichaivejvivat PCL's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Srivichaivejvivat PCL (BKK:VIH-R), the current EV-to-EBIT is 6.89 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Srivichaivejvivat PCL (BKK:VIH-R) Overvalued in 2026?
Based on GuruFocus' analysis, Srivichaivejvivat PCL stock appears to be undervalued.
The current stock price of ฿8.95 is trading 0.1% below its estimated GF Value™ of ฿8.96.
Key valuation signals for BKK:VIH-R:
EV-to-EBIT: 6.89 (46% below median its 10-year median of 12.86)
GF Value™: ฿8.96 vs. price of ฿8.95 (0.1% below fair value)
Industry Position: 56.3% below the Healthcare Providers & Services median (#71 of 471)
No single metric tells the full story. See the BKK:VIH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Srivichaivejvivat PCL is engaged in hospital business. The company provides 24-hour medical treatment by specialized doctors, with services in the outpatient department (OPD) by specialized doctors until midnight. Specialized clinics are available, such as comprehensive laparoscopic surgery, orthopedic surgery, urology, vascular surgery, cardiology, nephrology and hemodialysis center, endocrinology, neurology, gastroenterology, pediatric clinic, obstetrics and gynecology clinic, emergency accident center, dental center, health check-up center, Thai Filos Anti-Aging Center. It operates in single segment of hospital business in Thailand only.
81GF Score
Get the complete analysis for BKK:VIH-R
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:VIH-R has been successfully added to your 
